A comparative study of the anticancer efficacy of doxorubicin carrying microspheres and liposomes using a rat liver tumour model.Jim Codde, Bruce N. Gray, Mark A. Burton et al.|PubMed|1993Cited by 21
Immunohistochemical characterisation of immunological changes at the tumour site after chemo-immunotherapy with doxorubicin, interleukin-2 and interferon-gamma.Angela J. Lumsden, Bruce N. Gray, Peter H. van der Meide et al.|PubMed|1996Cited by 6
Improved efficacy of doxorubicin by simultaneous treatment with interferon-gamma and interleukin-2.Angela J. Lumsden, Peter H. van der Meide, Jim Codde et al.|PubMed|1993Cited by 5
Influence of schedule on the therapeutic efficacy of chemoimmunotherapy with doxorubicin and interleukin-2Angela J. Lumsden, Bruce N. Gray, Jim Codde|Biotherapy|1992Cited by 3
Prevention of myelosuppression does not improve the therapeutic efficacy of chemo-immunotherapy.Angela J. Lumsden, Peter H. van der Meide, Bruce N. Gray et al.|PubMed|1992Cited by 2